First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study
一线卡瑞利珠单抗(一种PD-1抑制剂)联合阿帕替尼(一种VEGFR-2抑制剂)和化疗治疗晚期胃癌(SPACE):一项1期研究
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-024-01773-9
Chen, Xiaofeng; Xu, Hao; Chen, Xiaobing; Xu, Tongpeng; Tian, Yitong; Wang, Deqiang; Guo, Fen; Wang, Kangxin; Jin, Guangfu; Li, Xiao; Wang, Rong; Li, Fengyuan; Ding, Yongbin; Tang, Jie; Fang, Yueyu; Zhao, Jing; Liu, Liang; Ma, Ling; Meng, Lijuan; Hou, Zhiguo; Zheng, Rongrong; Liu, Yang; Guan, Ni; Zhang, Bei; Tong, Shuang; Chen, Shiqing; Li, Xing; Shu, Yongqian